Progress in PBC: Seladelpar in Trial as Second-Line Therapy

This podcast explores the potential of new drugs, including seladelpar, for the treatment of primary biliary cholangitis (PBC). It discusses the effectiveness of seladelpar in improving liver tests, serum biochemistry, and symptom relief. The podcast also highlights the benefits of seladelpar in preventing cirrhosis and improving quality of life in PBC patients. Additionally, it addresses the safety of seladelpar and its potential in addressing symptoms such as itching, fatigue, and abdominal discomfort.